Molecular mechanisms associated with tumor metastasis remain poorly understood. Here we report that acquired expression of periostin by colon cancer cells greatly promoted metastatic development of colon tumors. Periostin is overexpressed in more than 80% of human colon cancers examined with highest expression in metastatic tumors. Periostin expression dramatically enhanced metastatic growth of colon cancer by both preventing stress-induced apoptosis in the cancer cells and augmenting endothelial cell survival to promote angiogenesis. At the molecular level, periostin activated the Akt/PKB signaling pathway through the ␣ v ␤ 3 integrins to increase cellular survival. These data demonstrated that the survivalpromoting function is crucial for periostin to promote tumor metastasis of colon cancer.
Introduction
few of the large number of cancer cells shed from a primary tumor ever form metastatic tumors Weiss, 1990; Wong et al., 2001) . As a consequence of this The process of malignant transformation involves the sequential acquisition of a number of genetic and epigenetic alterations complexity, the metastatic process involves genetic changes that underlie alterations in a variety of cellular functions for both as a result of increasing genomic instability caused by defects in checkpoint controls (Abraham, 2001; Hahn and Weinberg, cancer cells and the host environment, including the control of cell proliferation, survival, motility, cell-cell adhesion, and 2002; Hanahan and Weinberg, 2000; Nowak et al., 2002) . In humans, these alterations allow cancer cells to acquire the capainteractions with the extracellular matrix (ECM) (Jacks and Weinberg, 2002; Liotta and Kohn, 2001; Weaver et al., 2002) . Albilities to become self-sufficient in mitogenic signals, deregulate the control of cell cycle, escape from apoptosis, and obtain though it is clear that those genetic changes often lead to alterations in the expression pattern of specific genes, relatively little unlimited replication potential via the reactivation of telomerase (Artandi and DePinho, 2000; Blasco, 2002; Hanahan and Wein- is known about the nature of those molecular events that are directly involved in the metastatic process. berg, 2000). Within a growing tumor mass, the genetic changes during tumor progression also enable cancer cells to gain the As the second leading cause of death from malignancy in the United States, colorectal cancer is the most common type ability to induce angiogenesis, invade neighboring tissues, and metastasize to distant organs (Cavallaro and Christofori, 2000;  of tumor to metastasize to the liver (Markowitz et al., 2002; Takeda et al., 2002) . Actually, metastasis accounts for the major- Chambers et al., 2002; Folkman, 2002) .
The development of metastatic tumors consists of a series of ity of mortality associated with colorectal cancer, making an effective treatment of this disease a complicated goal. Taking complex sequential events. Neoplastic cells within the primary tumor mass have to journey through multiple steps, including advantage of the availability of both primary and metastatic tumor samples from the same patients with metastatic colon intravasation into the circulation, survival in the circulation systems, arrest and extravasation into a new tissue, initiation and cancers, we searched for genes upregulated during metastasis and report here the identification of periostin as a candidate maintenance of growth, and reactivation of angiogenesis, in order to successfully establish metastatic colonies in distant gene whose acquired expression by colon cancers is associated with enhanced tumor metastatic growth and angiogenesis, priorgans MacDonald et al., 2002) . Hence, marily by promoting cell survival for both cancer cells and endothelial cells.
Results

Periostin is differentially expressed in human primary colon carcinomas and metastatic tumors
In order to identify genes that are potentially involved in promoting late-stage progression of colon cancers, particularly metastasis, we performed a series of differential cDNA display analyses on mRNA samples isolated from normal colon tissue, primary colon cancer, and metastatic tumor in the liver derived from the same patient. One of the genes identified to have a differential expression pattern among these three types of samples was periostin ( Figure 1A ). Periostin is a secreted protein that was originally isolated from osteoblasts and found to be preferentially expressed in periosteum in bone tissue (Horiuchi et al., 1999; Takeshita et al., 1993) . Periostin contains an N-terminal secretory signal peptide, followed by a cysteine-rich domain, four internal homologous repeats, and a C-terminal hydrophilic domain. The four internal repeats region of periostin shares a homology with the axon guidance protein fasciclin I that is involved in the development of nervous system in invertebrates (Zinn et al., 1988) .
To determine if the observed upregulation of periostin is a common feature of colon cancer progression, we performed Northern blot analysis on 29 pairs of matched normal colon tissue and colon tumor samples. As shown in Figures 1B and  1C , periostin was found to be differentially overexpressed in more than 80% of human primary colon cancer samples examined. Quantitative analysis indicated that two-thirds (20 of 29 cases) of examined primary colon carcinomas showed a tumor/ normal (T/N) ratio of periostin message expression higher than Figure 1D ). Furthermore, we found metastatic tumor to the liver (M) and the matched primary colon tumor (T) that periostin was overexpressed in all cases of colon metastatic versus normal colon tissue (N) from the same patient.
35 S-labeled PCR cDNA tumors in the liver ( Figure 1C ). Importantly, the expression level fragments from mRNA of these three types of samples from the same patient of periostin in the hepatic metastases derived mostly from pawere displayed based on their molecular sizes.
tients with relapses of their colon cancers was noticeably higher B: Northern blot analysis of periostin message expression in paired primary colon tumor (T) and normal colon tissue (N) from the same patient. Total than that in the matched primary colon tumors from the same RNA samples from matched tissues were probed with the human periostin patients in 8 out of 9 cases examined ( Figures 1C and 1E ).
cDNA labeled with [␣-32 P] dCTP. The same blot was probed with GAPDH Quantitative and statistical analysis indicated that the average for loading control.
T/N ratio of periostin message expression in those hepatic me-C: Higher expression level of periostin mRNA was found in the metastatic tumor (M) in the liver than in the matched primary colon tumor (T) from the tastases was 2.6-fold of that in the matched colon primary same patient in 5 out of 6 representative cases. Normal colon tissue (N) tumors, and the difference in periostin message expression beand normal liver tissue (L) were used as controls.
tween the hepatic metastases and their matched colon primary
The number of colon primary carcinoma cases is plotted against the tumors was significant (p Ͻ 0.02) ( Figure 1E ). These results range of Tumor/Normal (T/N) ratios of hybridization signal for the matched suggest that late-stage metastatic tumors express higher levels samples from the Northern blot analysis in B and C. Two-thirds of colon carcinomas showed 5-to 15-fold periostin overexpression in contrast to the of periostin, which may play a role during the metastatic stage matched normal colon tissues.
of colon cancer progression.
E:
The average Tumor/Normal (T/N) ratios of periostin expression between
To determine if the periostin protein is overexpressed in the liver metastases (MET) and the matched colon primary tumors (CPT) colon cancer cells in the tumor tissues, we examined a series were quantified and plotted. Statistical analysis indicated that the periostin message expression in the hepatic metastases (MET) derived mostly from of matched tissue sections, including normal colon mucosae, patients with relapses of their colon cancers was significantly higher (p Ͻ primary colon tumors, and metastases in the liver, from the 0.02) than that in their matched colon primary tumors (CPT).
same patients by immunohistochemical staining with an antibody against human periostin. The anti-periostin polyclonal antibody was purified through an affinity column and shown to recognize specifically the periostin protein ( Figure 3A ). The imas 9 cases of matched hepatic metastases derived mostly from munohistochemical staining for periostin was performed on 25 patients with relapses of their colon cancers. As shown in Figure  cases of primary colon carcinomas, including 8 cases of stage 2, the immunostaining analyses indicated that high levels of periostin were present in areas containing cancer cells of the II, 9 cases of stage III, and 8 cases of stage IV tumors, as well primary colon tumors (Figures 2B and 2C) and metastatic tumors in the liver ( Figure 2D ). In contrast, periostin was undetectable in normal colon mucosae (Figure 2A) . Consistent with the message expression analysis, more intense periostin staining was seen in the hepatic metastases ( Figure 2D ) derived from the patients with late relapses than that in the matched colon primary tumors ( Figure 2B ). Overall, the majority (75%) of primary colon tumors displayed prominent levels of periostin staining, whereas periostin was hardly detectable in all matched normal colon tissues. Quantitative analysis of the periostin immunohistochemistry staining results with a SAMBA 4000 computerized image analysis system with the Immuno 4.0 quantitative program indicated that the average mean optical density (MOD) of periostin staining in the stage II, stage III, or stage IV primary tumors is much higher than that in their matched normal colon mucosae in each group, respectively (p Ͻ 0.01, Figure 2E) . Furthermore, the quantitative and statistical analysis revealed that the average MOD of periostin protein staining in the hepatic metastases was found to be 2.7-fold of that in the matched colon primary tumors, and the difference was significant (p Ͻ 0.02, Figure 2F ). Taken together, these observations indicate that higher levels of periostin expression were associated with metastasized colon tumors.
Overexpression of periostin in colon cancer cells potently promote metastatic tumor growth in the liver
To assess the functional significance of elevated periostin expression levels during the progression of colon cancer, we investigated whether stable overexpression of periostin in a human colon cancer cell line could alter its metastatic potential in vivo when grown as xenografts in immune-compromised mice. For this purpose, we selected a subline of the human colon cancer cell line CX-1, CX-1NS, that expresses a very low level of endogenous periostin and displays negligible metastatic potential in vivo ( Figure 3A and data not shown). A C-terminally His-tagged periostin expression construct was transfected into into the nude mice to assess the potential differences in tumor cantly higher than that from the matched normal colon mucosae in each growth between the periostin-overexpressing and the vector group, respectively (p Ͻ 0.01).
control clones. As shown in Figure 3C , periostin overexpression environment, the effect was moderate.
We next examined whether periostin overexpression could affect the metastatic potential and growth of the cancer cells in vivo. Equal numbers of cells (6 ϫ 10 6 /animal) of the three periostin-producing CX-1NS clones or the three vector-trans- in the liver (T1-T5). However, no visually observable liver metastases were B: Overexpression of periostin in CX-1NS cells resulted in cellular morphologiseen in the mice injected with the same number of vector-transfected CXcal change with an appearance of fibroblast-like cell shape.
1NS control cancer cells (C1-C5). Large metastatic tumors derived from the C: The tumor weights of subcutaneous tumors derived from three clones of periostin-producing CX-1NS colon cancer cells were seen to occupy almost periostin-overexpressing CX-1NS cells (A12, B08, B19) and three clones of the entire liver in some mice (T1, T2, T5). Arrows indicate the metastatic vector control CX-1NS cells (V03, V04, V05). The average ratio of tumor tumors in the mouse liver (T1, T2) and the normal liver in the control mice weight between periostin-expressing CX-1NS tumor and vector control CX-(C1, C2). The isolated livers from control mice (C3-C5) and the livers with 1NS tumor is less than 2-fold.
huge metastatic tumors (T3-T5) are shown in the lower part of the figure.
B:
The weights of metastatic tumors in the liver isolated from 16 animals survived the procedure with injection of the periostin-overexpressing CX-1NS cells and from 17 mice injected with the control cells were collected fected controls were introduced into the nude mice via intraand plotted together. Three periostin-overexpressing clones (A12, B08, and splenic injection. Five weeks after the inoculation of tumor cells, B19) and three vector control clones (V03, V04, and V05) were used in these experiments.
the animals were sacrificed for the examination of metastatic growth in the liver and other organs. Strikingly, multiple large tumor metastases were detected in the livers of 15 out of 16 mice that survived the procedure with injection of the periostinupon examination with a dissecting microscope. The tumor producing CX-1NS cells (Figure 4) , with a majority of the metaweights of liver metastases isolated from each mouse of the two static tumors grown to the extent to occupy almost the entire groups were plotted and shown in Figure 4B . Overexpression of liver (T1, T2, T4, T5 in Figure 4A ). In contrast, no visually observperiostin in colon cancer cells therefore strongly promoted tuable metastatic tumors were found in the livers of the 17 control mor metastatic growth in vivo, supporting a critical role for mice injected with the control cells (C1-C5 in Figure 4A ), although 1-2 small tumor nodules were found in 6 of these mice periostin in the late stage of tumor progression.
Overexpression of periostin enhanced vascularization and reduced apoptosis in the growth of metastatic tumors in the liver
Since the extent of the enhanced metastatic growth due to the overexpression of periostin is far more dramatic than that of the enhanced subcutaneous growth by the same cancer cells (compare Figures 4B and 3C ), we speculated that the periostinmediated metastatic tumor development in the liver was unlikely only due to increased rate of tumor cell growth in vivo, and some other cellular activities promoted by periostin protein may also contribute to the fast metastatic development of the periostinoverexpressing colon cancer cells in the liver. During the process of dissecting the metastatic tumors, we noticed that all metastases derived from the periostin-producing CX-1NS cancer cells displayed high levels of hemorrhaging (T1-T5 in Figure 4A ), suggestive of elevated degrees of vascularization. To address this possibility, we examined the blood vessel density on the sections of those metastatic tumors by using immunohistochemical staining with the antibody MECA32 (antimouse panendothelial antigen), which recognizes an epitope constitutively expressed on vascular endothelium of most tissues including tumor nodules (Harmey et al., 2002) . Quantitative analysis of vessel density of three metastases for each CX-1NS clone revealed that the blood vessel density of the metastatic tumors derived from the periostin-overexpressing CX-1NS cells is approximately 5-fold higher than that of the rare micrometastases derived from the control cells ( Figure 5A ). As shown in Figure 5B with the representative staining pattern of blood vessels, the metastatic tumors derived from the periostin-producing CX-1NS cancer cells were much more intensely vascularized than the small metastatic nodules derived from the control cancer cells. These results strongly suggest that periostin secreted by tumor cells may act in a paracrine manner to induce tumor angiogenesis during metastatic growth, a finding consistent with the notion that tumor angiogenesis is essential for the successful Figure 5 . Analysis of blood vessel density and extent of apoptosis in the metastatic tumor sections development of metastases Folkman, 2002; Takeda et al., 2002) . lesser extent of apoptosis that favors metastases development color) were present in the small metastatic nodules derived from the vectortransfected CX-1NS control cells, but little apoptosis was seen in the large in vivo, an outcome that can at least partially be attributed to metastases derived from the periostin-producing CX-1NS cancer cells.
the induction of angiogenesis.
Periostin expression enabled cancer cells to successfully establish metastases in the liver
by intraportal vein injection, and the formation of GFP-labeled To further probe if the overexpression of periostin has a direct micrometastases in the liver was examined on day 5 and day impact on the initial stage of micrometastatic colony formation, 10 after injection. On day 5, the density of micrometastases or we introduced the green fluorescent marker GFP into the periossolitary cancer cells in the liver derived from the periostin/GFP/ tin-producing and the control CX-1NS cells. Equal numbers of CX-1NS cells and the vector/GFP/CX-1NS controls was not cells (6 ϫ 10 6 /animal) of the periostin/GFP/CX-1NS clones or the vector/GFP/CX-1NS controls were injected into nude mice significantly different as revealed by the presence of approxi- mately equal numbers of GFP fluorescent-labeled colonies or single cells on liver sections ( Figures 6A and 6B ). On day 10, however, we found that those metastases derived from periostin/GFP/CX-1NS cells had grown to form larger metastatic colonies ( Figure 6C ), although the overall number of metastases was reduced. In contrast, those micrometastatic nodules de- 
conditions of growth stress
To explore the mechanism at the cellular level by which periostin promotes tumor metastasis and growth, we examined the biological effects of periostin on both tumor cells and the human ures 7D and 7E), which is compatible with the survival-promotmicrovessel endothelial cells (HMVECs) that are known to play ing effect induced by the potent angiogenic factor VEGF. In an essential role in tumor angiogenesis under in vitro conditions addition, we observed that periostin overexpression or the presthat mimic the cellular stress inside metastatic tumors, such ence of the recombinant periostin protected both tumor cells as hypoxia and nutrient deprivation with serum depletion. As and HMVECs from undergoing anoikis, the cell death induced shown in Figures 7A and 7B , results from three independent by loss of adhesion. When the control CX-1NS cells were culexperiments with three clones (A12, B08, and B19) revealed that tured in the Petri dish coated with PolyHema to prevent adheperiostin-producing CX-1NS cells were indeed more resistant to sion, they displayed massive anoikis in 5 days ( Figure 7C , left). serum starvation and hypoxia in comparison to three clones of However, most periostin-producing CX-1NS cells survived unthe control cells (V03, V04, and V05). Similarly, the recombinant der the same condition ( Figure 7C , right). Similar results were periostin was shown to enhance the ability of HMVECs to survive under the same serum depletion and hypoxic conditions (Figobtained with HMVECs untreated or treated with 100 ng/ml of recombinant periostin for 4 days ( Figure 7F ). Taken together, these data demonstrate that periostin could act to promote cellular survival for both tumor cells and endothelial cells under stress conditions that are commonly associated with the metastatic tumor and a fast-growing tumor mass, such as hypoxia, nutrient depletion, and loss of adhesion.
Periostin activated the Akt/PKB pathway via the ␣ v ␤ 3 integrins to promote cellular survival To explore the molecular mechanism by which periostin promotes cellular survival, we examined the potential effect of periostin on the activities of several known cellular survival pathways. To this end, we found that periostin expression or treatment with the recombinant periostin in both CX-1NS cancer cells and HMVECs led to activation of the Akt/PKB signaling pathway as measured by the specific phosphorylation of Akt1/ PKB␣ on Ser473. As shown in Figure 8A , Ser473 phosphorylation that indicates the activation of Akt/PKB pathway (Nicholson and Anderson, 2002) was readily detected in the periostin-producing CX-1NS cells, but not in the parental and vector-transfected CX-1NS cells under the serum-free condition. Similarly, treatment of HMVECs with 100 ng/ml periostin under the serumfree condition led to Akt1/PKB␣ phosphorylation on Ser473 ( Figure 8B) . A recent report indicated that periostin could bind to the ␣ v ␤ 3 and the ␣ v ␤ 5 integrins in ovarian cancer cells (Gillan et al., 2002) . To probe if the integrins are involved in the mediation of periostin action, we pre-incubated the CX-1NS cells and HMVECs with antibodies against each of these two integrins and measured the phosphorylation of Akt1/PKB␣ on Ser473 induced by the presence of periostin. As shown in Figures 8A  and 8B , the results indicate that activation of the Akt/PKB sur- The findings presented here demonstrated the validity and fruitfulness of our approach in identifying specific genes whose PKB survival pathway. altered expression pattern is intimately associated with later development of metastases ; Hynes, stages of tumorigenesis, particularly metastasis. Through exten-2003). Our results indicate that the presence of periostin did sive functional analyses, one of the candidate genes identified not significantly affect the initial formation of micrometastases in by this approach, periostin, was shown to promote later stages the liver in the animal models, but that it did stimulate metastatic of tumor progression. A colon cancer cell line with a low metagrowth and development at later stage by promoting cancer static potential engineered to overexpress periostin displayed cell survival and inducing angiogenesis. Thus, periostin secreted a striking phenotype of greatly accelerated tumor metastatic by the tumor cells functions to promote the survival of tumor growth as xenografts in the animal model system of metastasis.
cells, in addition to playing a role in a paracrine manner to The underlying mechanism of periostin-mediated promotion of augment the survival of endothelial cells and induce neovascutumor metastasis is largely associated with the ability of perioslarization, an activity consistent with the notion that enhanced tin to enhance cellular survival for both cancer cells and endosurvival of endothelial cells within tumors is critical for the sucthelial cells under stress conditions. The discovery of a link cessful development of tumor angiogenesis (Brooks et al., 1994 ; between periostin and the ␣ v ␤ 3 integrin-Akt/PKB signaling path- Scatena and Giachelli, 2002; Stupack and Cheresh, 2002) . The way provides a molecular explanation for the prosurvival activity dual functions of periostin on the two types of cells within the of periostin in the context of tumor progression through the tumor mass may contribute to the rapid development and estabsuccessful development of angiogenesis and establishment of lishment of metastases in the liver. Since this protein is intimately metastatic colonies, as both the ␣ v ␤ 3 integrins and the Akt/ involved in the critical rate-limiting steps of tumor metastatic PKB pathway have been implicated to play important roles in process, periostin could be a potential target for the developpromoting cell survival and tumorigenesis (Brooks et al., 1994;  ment of novel treatment for metastatic colon cancers. Nicholson and Anderson, 2002; Stupack and Cheresh, 2002) .
At the mechanistic level, it is not surprising that we found In addition to playing a critical role in the progression of periostin to exert its effect via the integrins, as a large number colon cancers, periostin appears to be involved in other human of studies have demonstrated that interactions between integcancers as a recent report showed that serum levels of periostin rins on the surface of tumor cells and adhesion molecules in are elevated in patients with bone metastases from breast canthe ECM microenvironment are extremely important for tumor cer (Sasaki et al., 2003) and periostin expression is upregulated cell migration, survival, and growth in different anatomical locain ovarian cancers (Ismail et al., 2000) . In a separate study, we tions to form distant metastases (Green and Evan, 2002 ; Jacks have found that periostin was overexpressed by a majority of and Weinberg, 2002; Liotta and Kohn, 2001; Weaver et al., breast cancers examined by genearray analysis (data not 2002). The ECM-integrin interactions are not only critical for shown). Interestingly, ␤ig-h3, a secreted RGD sequence-contumor cell survival, but also important to trigger intracellular taining protein that shares a significant structural homology with signaling and activation of certain genes that lead to tumor cell periostin, was also found by SAGE analysis to be differentially proliferation during metastatic growth (Meredith and Schwartz, overexpressed in human colon cancer (Zhang et al., 1997 (Zhang et al., ), indi-1997 . In addition, the interactions between cell surface integrins cating that ␤ig-h3 may be similarly involved in promoting tumoriand ECM components are also essential for the survival of genesis. However, ␤ig-h3 does not contain the sequence hoendothelial cells and the formation of blood vessels within the mologous to the C-terminal hydrophilic domain in periostin, tumor mass (Brooks et al., 1994; Scatena and Giachelli, 2002 ; suggesting that functional differences may exist between the Stupack and Cheresh, 2002). The life and death decision at the two proteins during tumor development. cellular level is controlled by the proper cell-matrix interactions Tumor metastatic process consists of multiple and complex steps, all of which must be successfully completed to give rise to (Jacks and Weinberg, 2002; Stupack and Cheresh, 2002) . Thus, the outgrowth of metastatic tumors in a new organ environment tumor cells that are unable to adapt to the new microenviron- Folkman, 2002) . During this process, ment in distant sites lose their ability to form metastases. Withcancer cells have to overcome many types of stresses such as out acquiring specific genetic changes, most cancer cells reachhemodynamic shearing, loss of adhesion, nutrient depletion, ing different anatomical tissues are unlikely to survive in the hypoxia, and accumulation of wastes that may all induce cell new ECM environment and are unable to initiate metastatic death. Furthermore, it has been recognized that metastasis is growth, providing a plausible explanation for the low efficiency a relatively inefficient process Luzzi et of metastatic process. In this regard, acquired expression of al., 1998; Weiss, 1990) . Although early steps in the hematogeperiostin and similar types of proteins may enable tumor cells nous metastatic process from the entry of cancer cells to the to thrive in the new environment of distant organs and grow as bloodstream until their extravasation into secondary organs are successful metastatic colonies. remarkably efficient, subsequent steps associated with the establishment of metastases are completed inefficiently, with only Experimental procedures a small number of cancer cells being able to initiate the formation Differential cDNA display and Northern blot analysis of micrometastases in the secondary site, and an even smaller Differential cDNA display and Northern blot analysis were performed as subset of those micrometastases evolving into macroscopic described previously . Poly(A) ϩ mRNA used for the display metastases MacDonald et al., 2002;  was purified from total RNA by using Oligotex mRNA kit (Qiagen, Valencia, Naumov et al., 2002) . Two critical aspects that allow micromet- survive and grow in the distant organ is critical for the successful Immunohistochemical staining and analysis of tumor each clone. 4 weeks after injection, mice were sacrificed and examined for the growth of subcutaneous tumors. vascular density Paraffin-embedded colon tumor and normal tissue sections were processed Apoptosis assay for antigen retrieval by heating in 10 mM sodium citrate (pH 6.0) at 95ЊC
To examine the apoptotic events in the liver metastases derived from the for 20 min. Then, sections were immunostained with an affinity-purified periostin-producing CX-1NS cancer cells or the vector-transfected CX-1NS polyclonal antibody raised against the recombinant human periostin protein.
control cells, frozen sections of the metastatic tumors were analyzed by The immunostaining was performed with an ABC staining system (Vector using the ApoAlert DNA fragmentation assay kit (BD-Clontech). The assay Laboratories, Burlingame, CA) using avidin-biotinylated-peroxidase detecwas performed according to the user manual. Apoptotic cells appear in tion method. The immunostaining to detect the blood vessels in the metastagreen color with the FITC filter under a fluorescent microscope. ses of mouse liver with the MECA32 antibody (rat anti-mouse panendothelial antigen; Pharmingen, San Diego, CA) was performed as described (Harmey Periostin protein expression and purification et al., 2002) . The blood vessel density in tumor was calculated and quantified
The recombinant periostin protein was expressed in the insect cells using as previously described (Filleur et al., 2001; Vermeulen et al., 1996) . the baculovirus expression system (Invitrogen). A hexa-histidine tag was To insure the comparability of the periostin immunohistochemical stainadded to the C terminus of the human periostin. The detailed method can ing, a common reference standard was included to serve as an internal or be found in the Supplemental Data (http://www.cancercell.org/cgi/content/ intra-assay control in every slide as previously described (Sompuram et al., full/5/4/329/DC1). 2002a, 2002b). The detailed method is described in the Supplemental Data (http://www.cancercell.org/cgi/content/full/5/4/329/DC1).
Anoikis assay
To determine the effect of periostin on cell survival under anoikis-inducing Quantitative and statistical analysis of periostin condition, cells were prevented from adhering to the plastic dishes by culturimmunohistochemical staining ing them in Petri dishes coated with PolyHema (Sigma, St. Louis, MO) as deThe quantitative analysis of the immunohistochemical (IHC) staining for periscribed previously (Zhu et al., 2001) . The detailed assay is described in the ostin expression in tumor tissues was performed as previously described Supplemental Data (http://www.cancercell.org/cgi/content/full/5/4/329/DC1). (Mady and Melhem, 2002; Ang et al., 2002) . The staining of each tissue was analyzed to determine the Mean Optical Density (MOD), which represents Cell survival assay under hypoxia and serum-depletion conditions the concentration of the stain as measured per positive pixels. The detailed Periostin-producing CX-1NS cells and the vector-transfected CX-1NS cells method can be seen in the Supplemental Data (http://www.cancercell.org/ were grown in the normal medium until 60%-70% confluency. Then, they cgi/content/full/5/4/329/DC1).
were incubated with serum-free medium or treated with 100 M DFO (Deferoxamine; Sigma) to mimic hypoxia (Bianchi et al., 1999) for different time Cell culture and transfection points as indicated, and the numbers of survival cells at different time points CX-1NS cells were cultured in DMEM growth medium (Invitrogen Corp., were analyzed and counted. The results were quantified from three indepenCarlabad, CA) supplemented with 10% FBS and antibiotics. The human dent experiments with three periostin-expressing CX-1NS clones and three microvascular endothelial cells HMVECs (Clonetics, Walkersville, MD) were vector control clones. For endothelial cells, after HMVECs were grown in maintained in endothelial growth medium (EGM-2-MV; Clonetics) supplethe growth medium until 60%-70% confluency, the cells were incubated mented with 5% FBS (Clonetics). Cell transfections were performed using with serum-free basic medium containing 100 ng/ml of periostin, VEGF, or FuGene 6 reagent (Roche) according to the manufacture's instruction.
BSA, or were treated with 100 M DFO (Sigma) in the medium containing 100 ng/ml of periostin, VEGF, or BSA for different time points as indicated, Generation of periostin-producing colon cancer cells and the surviving cells were analyzed and counted at different time points. At To construct a periostin expression plasmid, the full open reading frame of least three independent experiments were performed to obtain the statistical human periostin cDNA was cloned into pcDNA3.1 mammalian expression results. vector (Invitrogen) with a hexa-histidine tag at COOH terminus of periostin protein. Then, the periostin/pcDNA3.1 plasmid or the vector alone was introWestern blot analysis duced into CX-1NS colon cancer cells, and the stable clones were obtained For the detection of secreted periostin protein, periostin-producing cells or by G418 selection (950 g/ml) in the culture medium. 3 of 5 periostincontrol cells were grown in normal medium until 80% confluency and then expressing clones and 3 of 6 control clones were chosen for the subsequent cultured in the serum-free medium for 24 hr. The serum-free conditional experiments. In order to observe the initial formation of the micrometastases medium were collected and analyzed by immunoblot with a specific antiin the liver, the GFP plasmid (pEGFP; Clontech, Palo Alto, CA) was introduced periostin polyclonal antibody, anti-His antibody (H-15 or H-3; Santa Cruz into two of those periostin-producing CX-1NS clones and two of the Biotechnology), anti-VEGF polyclonal antibody (Ab-4, Calbiochem, La Jolla, pcDNA3.1 vector-transfected control clones to stably express the green CA), and anti-IL-8 mAb (B2, Santa Cruz). The specific anti-periostin antibody fluorescent marker.
was generated by immunizing the rabbits with recombinant periostin protein and purified through an affinity column. For the detection of Akt and other Xenograft assays in nude mice proteins, cell lysates were analyzed by immunobloting with the anti-Akt1/ To examine whether periostin expression in colon cancer cells affects meta-PKB␣ (#9272) and anti-pS473-Akt1/PKB␣ (#9271) rabbit polyclonal antibodstatic growth in the liver, periostin-expressing CX-1NS cells (6 ϫ 10 6 /animal) ies (Cell Signaling Technology Inc., Beverly, MA). Anti-␣ v ␤ 3 mAb (LM609; were injected into female nude mice (Charles River, Raleigh, NC) via intraChemicon Inc., Temecula, CA) and anti-␣ v ␤ 5 mAb (PIF6; Chemicon) were splenic injection as previously described (Khatib et al., 1999) . The control used at 10 g/ml for the functional blocking experiments. groups were injected with the same number of vector-transfected CX-1NS cancer cells. Three periostin-overexpressing clones (A12, B08, and B19) and PTEN retrovirus and the Akt inhibitor three vector control clones (V03, V04, and V05) were used in this experiment.
The PTEN retroviral construct was generated by inserting the PTEN fullSeven to eight mice were injected for each clone. The mice that survived length open reading frame into the retroviral backbone vector pBabe with the procedure were sacrificed 5 weeks after injection and examined for a puromycin selection marker. The production of the retrovirus and the metastases development. To detect the GFP-labeled micrometastases forinfection of cells for protein overexpression were performed as previously mation, periostin/GFP/CX-1NS cells (6 ϫ 10 6 /animal) or the same number described (Rich et al., 2003) . Control cells were infected with retrovirus of the vector/GFP/CX-1NSs were injected into nude mice by intraportal vein containing the backbone vector but without the PTEN cDNA. The Akt/PKBinjection. On day 5 and day 10 after injection, liver sections of mice from both specific inhibitor (1L-6-Hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-Ogroups were checked to detect GFP micrometastases under a fluorescent octadecylcarbonate) that has been shown to potently inhibit Akt/PKB (Hu microscope. For the subcutaneous injection, three clones of periostinet al., 2000) was obtained from Calbiochem. 15 M Akt/PKB inhibitor was expressing CX-1NS cells (5 ϫ 10 6 /animal) and three clones of vector control used to treat CX-1NS cells and HMVECs for the indicated experiments according to the manufacturer's instructions. CX-1NS cells (5 ϫ 10 6 /animal) were injected to SCID mice with 5 mice for
